Literature DB >> 10989466

Visual pathway tumors and hydrocephalus.

A Shuper1, L Kornreich, S Michowitz, M Schwartz, I Yaniv, I J Cohen.   

Abstract

The authors evaluated the impact of hydrocephalus on the clinical picture of children with visual pathway tumor (VPT) with or without neurofibromatosis (NF). Charts of children with VPT treated in the authors' center since 1985 were retrospectively reviewed, and those with hydrocephalus were selected and summarized. Thirty-five children with VPT were found, of whom 20 had NF. Hydrocephalus was found in 4 children with NF (20%) and in 5 without NF (33.3%). In 6 of the children, ventricular dilatation with signs of acute increased intracranial pressure already existed at the time of diagnosis and the hydrocephalus was shunted at this time. In the other 3 children, all with NF, the hydrocephalus resulted from slowly developing aqueductal stenosis, leading in 2 to severe visual acuity deterioration. The results suggest that in children with VPT and NF, hydrocephalus, and especially hydrocephalus resulting from aqueductal stenosis, is more frequent than in the general population of NF patients, and less frequent than in VPT patients without NF. The possibility of the indolent development of hydrocephalus should be borne in mind while following children with NF. The optic nerve, when already involved with a glioma, is more vulnerable to increased pressure. Thus, in children with VPT and NF, any ventricular dilatation should lead to a consideration of early shunting.

Entities:  

Mesh:

Year:  2000        PMID: 10989466     DOI: 10.1080/08880010050120818

Source DB:  PubMed          Journal:  Pediatr Hematol Oncol        ISSN: 0888-0018            Impact factor:   1.969


  4 in total

1.  Suprasellar pilocytic astrocytoma: one national centre's experience.

Authors:  Tafadzwa Mandiwanza; Chandrasekaran Kaliaperumal; Ayman Khalil; Muhammad Sattar; Darach Crimmins; John Caird
Journal:  Childs Nerv Syst       Date:  2014-02-25       Impact factor: 1.475

2.  Mortality in Children with Optic Pathway Glioma Treated with Up-Front BB-SFOP Chemotherapy.

Authors:  Josué Rakotonjanahary; Emilie De Carli; Matthieu Delion; Chantal Kalifa; Jacques Grill; François Doz; Pierre Leblond; Anne-Isabelle Bertozzi; Xavier Rialland
Journal:  PLoS One       Date:  2015-06-22       Impact factor: 3.240

3.  Visual Outcome for Children with Optic Pathway Gliomas Treated with Systemic Chemotherapy.

Authors:  Mona Mohammad; Hamzeh Mohammad Alrawashdeh; Mustafa Mehyar; Nisreen Amayiri; Dima Abu Laban; Ibrahim Alnawaiseh; Yacoub Yousef
Journal:  Clin Ophthalmol       Date:  2022-09-01

Review 4.  Management of Optic Pathway Glioma: A Systematic Review and Meta-Analysis.

Authors:  Omid Yousefi; Pouria Azami; Mohammadmahdi Sabahi; Rocco Dabecco; Badih Adada; Hamid Borghei-Razavi
Journal:  Cancers (Basel)       Date:  2022-09-30       Impact factor: 6.575

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.